Travere Therapeutics Inc (TVTX)
Operating Expenses
$598.71M
TTM · Period ending: · USD
TVTX Operating Expenses
Latest reported$598.71Mperiod ending
Latest reported$598.71Mperiod ending
TVTX TTM Operating Expenses ($14.36K → $598.71M)
TTM operating expenses
High-resolution chart · PNG
TVTX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 598,711,000 | |
| 560,833,000 | |
| 543,212,000 | |
| 516,619,000 | |
| 495,697,000 | |
| 478,880,000 | |
| 538,260,000 | |
| 516,771,000 | |
| 527,741,000 | |
| 553,675,000 | |
| 506,726,000 | |
| 516,235,000 | |
| 491,257,000 | |
| 474,129,000 | |
| 445,370,000 | |
| 426,922,000 | |
| 421,845,000 | |
| 392,559,000 | |
| 382,471,000 | |
| 447,390,000 | |
| 418,439,000 | |
| 400,205,000 | |
| 368,360,000 | |
| 259,507,000 | |
| 252,419,000 | |
| 259,276,000 | |
| 263,922,000 | |
| 263,263,000 | |
| 259,521,000 | |
| 242,177,000 | |
| 227,169,000 | |
| 216,070,000 | |
| 201,977,000 | |
| 190,734,000 | |
| 183,605,000 | |
| 183,457,000 | |
| 186,483,000 | |
| 179,046,000 | |
| 168,868,000 | |
| 160,303,000 | |
| 149,187,000 | |
| 138,562,000 | |
| 129,966,796 | |
| 124,484,759 | |
| 119,707,470 | |
| 114,490,532 | |
| 106,267,484 | |
| 85,078,720 | |
| 58,638,495 | |
| 38,700,335 | |
| 23,972,071 | |
| 12,508,033 | |
| 7,356,547 | |
| 2,259,654 | |
| 12,928 | |
| 12,785 | |
| 12,810 | |
| 12,825 | |
| 12,647 | |
| 12,720 | |
| 12,695 | |
| 12,689 | |
| 19,214 | |
| 19,141 | |
| 19,209 | |
| 20,210 | |
| 14,356 | |
| 14,388 | |
| 14,696 |